In this case report, we describe the case of a 27-year-old woman with a long-standing history of chronic phase (CP) CML who developed kinase-independent resistance with mutations in <i>ASXL1</i> and <i>RUNX1</i>. The gene discussed is RUNX1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.